UK Markets open in 7 hrs 28 mins

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
116.16+0.33 (+0.28%)
At close: 04:00PM EST
115.48 -0.68 (-0.59%)
After hours: 07:12PM EST

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States
949 250 2500
https://www.edwards.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees14,900

Key executives

NameTitlePayExercisedYear born
Mr. Michael A. MussallemChairman & CEO2.09M73.15M1953
Mr. Scott B. UllemCorp. VP & CFO1.06M15.79M1967
Mr. Donald E. Bobo Jr.Corp. VP of Strategy & Corp. Devel.970.81k11.44M1962
Mr. Larry L. WoodCorp. VP of Transcatheter Aortic Valve Replacement1.01M7.78M1966
Mr. Jean-Luc LemercierCorp. VP of Europe, Middle East, Africa, Canada & Latin America1.13M2.42M1957
Dr. Todd J. BrintonCorp. VP of Advanced Technology & Chief Scientific OfficerN/AN/AN/A
Mark WilterdingVP of Investor RelationsN/AN/AN/A
Mr. Arnold A. PinkstonCorp. VP & Gen. CounselN/AN/A1959
Mr. Dirksen J. LehmanCorp. VP of Public AffairsN/AN/AN/A
Ms. Christine Z. McCauleyCorp. VP of HRN/AN/A1965
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Corporate governance

Edwards Lifesciences Corporation’s ISS governance QualityScore as of 26 September 2021 is 4. The pillar scores are Audit: 4; Board: 8; Shareholder rights: 3; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.